Chronotherapy for asthma reveals that afternoon inhaled corticosteroids significantly improve lung function and reduce ...

Sanofi reports amlitelimab improved lung function in asthma, with new phase 3 trials planned across its respiratory pipeline.

Asthma Drugs Market Oral and injectable forms are expanding, especially for patients with severe asthma and those undergoing biologic treat ...

Exposing children with peanut allergy to proteins from the legume is an approved treatment to reduce the risk of allergic ...

Allergic asthma is asthma triggered by allergy. Managing this condition involves learning what triggers attacks and taking ...

The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% ...

Hazelnut oral immunotherapy was safe and effective, but cross-desensitization for patients who also had walnut and cashew ...

If you’re bothered by allergies every spring, you may pop a Benadryl or Claritin most mornings to make the days tolerable.

According to The Sun, even though the man had been managing symptoms of asthma for the last two years on his own with the help of inhalers and oral medications, doctors who were treating him found ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... most common adverse events recorded included headache, oral candidiasis, cough, and dysphonia. The new approval ...